Gynecological Devices Market to be Lucrative in Emerging Nations

Gynecological examination requires meticulous approach to avoid diagnostic error. Specialized devices such as vaginal speculums, curettes, forceps, and retractors are developed to ease the surgery. Moreover, gynecological examination chairs makes conditional screening less cumbersome for the gynecologist. Such innovative devices have augmented the gynecological devices market growth. Growing incidence of gynecological conditions such vaginitis, endometriosis, and uterine fibroids would generate demand for gynecological devices in hospitals and surgical centers. Cervical cancer is one of the most prevalent condition among women worldwide. Growing incidence of cervical cancer would propel the gynecological devices market growth during the forecast period (2016–2024).
The global gynecological devices market was valued at US$ 2,667.8 million in 2015 and is expected to witness a moderate CAGR of 6.3% during the forecast period (2016 – 2024).

Growing gynecological procedures and disorders
According to the Endometriosis UK, 10% of the population of women worldwide is affected by endometriosis (2016). Moreover, pelvic inflammatory disease (PID) is the second most common and serious complications among the women in the U.S. Aging further increases the risk of cervical cancer, uterine fibroids, and vaginitis. Surgeries are essential in complex gynecological indications. Being critical and complex surgical procedures, demand for advance gynecological devices would increase during the forecast period. This would propel the growth of gynecological devices market.

Patient safety is the major point of care for device manufacturers
Certain gynecological devices such as intra-uterine device (IUD), morcellators, and vaginal speculums can cause infection and skin rashes. Several cases of skin rashes and pelvic pain were reported among women in the U.S. until 2016, who used Essure IUD. The U.S. FDA therefore asked the manufacturer Bayer, to include a black box warning on the product pack. Considering their highly personal application areas, any adverse effects associated with the devices would severely dent growth prospects of the gynecological devices market. Advent of robotic surgery is expected to lead to further innovations in gynecological devices in future. Companies therefore, need to work closely with surgeons, in order to provide innovative solutions catering to their specific demands.

Highly populous emerging economies to be major target markets
Emerging economies such as India and China are home to over 80% of the global population (European Central Bank). A large population inadvertently creates a proportionally large patient pool. Manufacturers of gynecological devices can potentially target these emerging nations in Asia, Latin America, Africa and Middle East region for business expansion. Use of contraceptives is projected to increase in emerging nations with increasing awareness among the population and initiatives by various governments to encourage family planning. The Centers for Disease Control and Prevention (CDC) runs a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to create awareness and provide women in the low-income group or those who are uninsured, with regular breast and cervical cancer screening and diagnostic services. Growing awareness initiatives for women population is creating a demand for early diagnosis of a disease. Improving healthcare infrastructure would be an effective driver for gynecological devices market growth. A study published in the Journal of Mid-Life Health in 2014 concluded that nearly 90% of surgeries in rural India were conducted without histopathological diagnosis. However, healthcare investment in India is increasing which is expected to establish more hospitals and surgical centers thus, driving growth of the gynecological devices market.